Lipella Pharms Inc (LIPO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,856 | 2,782 | 4,225 | 2,185 | 1,354 |
| Receivables | N/A | 42 | 86 | 85 | 31 |
| TOTAL | $2,079 | $3,437 | $4,823 | $2,617 | $2,080 |
| Non-Current Assets | |||||
| PPE Net | 8 | 8 | 9 | 10 | 11 |
| Other Non-Current Assets | 263 | 275 | 24 | 47 | 70 |
| TOTAL | $271 | $283 | $33 | $57 | $80 |
| Total Assets | $2,350 | $3,720 | $4,856 | $2,674 | $2,160 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 463 | 608 | 392 | 388 | 460 |
| Accrued Expenses | 35 | 15 | 258 | 238 | 90 |
| Other current liabilities | 100 | 81 | 102 | 81 | 81 |
| TOTAL | $642 | $747 | $777 | $754 | $701 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 220 | 232 | 0 | 0 | 0 |
| TOTAL | $220 | $232 | $N/A | $N/A | $N/A |
| Total Liabilities | $862 | $979 | $777 | $754 | $701 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 4,621 | 4,621 | 4,467 | 2,549 | 1,209 |
| Common Shares | 1 | 0 | 0 | 0 | 0 |
| Retained earnings | -19,228 | -17,974 | -16,647 | -15,340 | -13,898 |
| TOTAL | $1,488 | $2,742 | $4,079 | $1,920 | $1,459 |
| Total Liabilities And Equity | $2,350 | $3,720 | $4,856 | $2,674 | $2,160 |